Functional Constipation
Conditions
Brief summary
Change from baseline in 12-week SBM frequency rate (SBMs/week) observed by the primary caregiver during the double-blind study intervention period.
Detailed description
Change from baseline in 12-week stool consistency observed by the primary caregiver during the double-blind study intervention period, Change from baseline in 12-week straining observed by the primary caregiver during the double-blind study intervention period, Change from baseline in 12-week proportion of days with fecal incontinence during the double-blind study intervention period (for subjects who have acquired toileting skills during daytime and nighttime or acquired toileting skills during daytime only)
Interventions
DRUGLinaclotide
Sponsors
Abbvie Deutschland GmbH & Co. KG
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Change from baseline in 12-week stool consistency observed by the primary caregiver during the double-blind study intervention period, Change from baseline in 12-week straining observed by the primary caregiver during the double-blind study intervention period, Change from baseline in 12-week proportion of days with fecal incontinence during the double-blind study intervention period (for subjects who have acquired toileting skills during daytime and nighttime or acquired toileting skills during daytime only) | — |
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in 12-week SBM frequency rate (SBMs/week) observed by the primary caregiver during the double-blind study intervention period. | — |
Countries
Bulgaria, Netherlands
Outcome results
None listed